These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15398705)

  • 21. [Recurrences of gonorrhea in men (the characteristics of the course and treatment)].
    Glozman VN; Borisenko KK
    Vestn Dermatol Venerol; 1990; (3):51-3. PubMed ID: 2195797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated treatment guidelines for gonorrhea infections.
    Fantasia HC
    Nurs Womens Health; 2013; 17(3):231-5. PubMed ID: 23773196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On methods of control of cure of female gonorrhea].
    Dobrovol'skiĭ IuN
    Vestn Dermatol Venerol; 1966 Jan; 40(1):73-5. PubMed ID: 5974388
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
    Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
    N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rocefin (ceftriaxone) in therapy of uncomplicated gonorrhea in males].
    Khrianin AA; Reshetnikov OV; Anpilogova AD
    Antibiot Khimioter; 2006; 51(8):35-7. PubMed ID: 18030782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonorrhea: the office management of acute infections.
    Davis L
    Calif Med; 1967 Jul; 107(1):4-7. PubMed ID: 6045488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftriaxone for treatment of uncomplicated gonorrhea: routine use of a single 125-mg dose in a sexually transmitted disease clinic.
    Handsfield HH; Hook EW
    Sex Transm Dis; 1987; 14(4):227-30. PubMed ID: 3438787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea.
    Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK
    Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectinomycin versus tetracycline for the treatment of gonorrhea.
    Karney WW; Pedersen AH; Nelson M; Adams H; Pfeifer RT; Holmes KK
    N Engl J Med; 1977 Apr; 296(16):889-94. PubMed ID: 139565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.
    Levy V; Pandori M; Berrada ZL; Relucio KI; Lopez TP; Samuel MC; Park IU
    Sex Transm Dis; 2016 Apr; 43(4):258-9. PubMed ID: 26967304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of uncomplicated gonorrhea in adults. New guidelines from the working group against gonorrhea].
    Aavitsland P; Høiby EA
    Tidsskr Nor Laegeforen; 1996 May; 116(13):1577-80. PubMed ID: 8685869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of female gonorrhea. Therapeutic results with pivampicillin-probenecid and penicillin procaine-probenecid combinations].
    Lacerda MH; Prates Nunes F; Gonçalves H; Caldeira JB
    Med Cutan Ibero Lat Am; 1976; 4(2):143-8. PubMed ID: 988452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.
    Kerani RP; Stenger MR; Weinstock H; Bernstein KT; Reed M; Schumacher C; Samuel MC; Eaglin M; Golden M
    Sex Transm Dis; 2015 Jan; 42(1):6-12. PubMed ID: 25504294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
    Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
    Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of penicillin regimen in treatment of women with culture positive gonorrhea.
    Jordan WC
    J Natl Med Assoc; 1980 Sep; 72(9):857-9. PubMed ID: 7420449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
    Golden MR; Barbee LA; Kerani R; Dombrowski JC
    Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of gonorrhea with a single dose of pivampicillin and failure to cure].
    Hagdrup H; Serup J
    Ugeskr Laeger; 1985 May; 147(19):1536-7. PubMed ID: 3848233
    [No Abstract]   [Full Text] [Related]  

  • 40. State Department of Health revised recommended schedules for gonorrhea.
    J Iowa Med Soc; 1975 Aug; 65(8):342-5. PubMed ID: 126264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.